<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02810535</url>
  </required_header>
  <id_info>
    <org_study_id>FRA.LISA.2015</org_study_id>
    <nct_id>NCT02810535</nct_id>
  </id_info>
  <brief_title>Local IgE in Subjects With Allergic or Non-allergic Rhinitis</brief_title>
  <acronym>LISA</acronym>
  <official_title>Local IgE in Subjects With Allergic or Non-allergic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the incidence of non-allergic rhinitis on a not
      selected group of young students (n=100-300). Students will be selected by public posting. In
      all students an allergy skin test will be performed. Then the local IgE of 24 subjects with
      non-allergic rhinitis will be compared to the local IgE of 24 subjects with allergic rhinitis
      and positive prick test to house dust mite. In addition 20 controlls will be investigated.
      Based on these investigations, the importance of local IgE and the IgE spectrum in
      conjunction with rhinitis should be further clarified.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      20% of Germans suffer from seasonal or all-season rhinitis. Despite typical allergic
      symptoms, in a part of the affected patients (about 10-20%) an allergy cannot be found on
      skin prick test or blood. Therefore, the planned trial will investigate the incidence of
      allergic and non-allergic rhinitis in a non selected group of young students (n=100-300). The
      hypothesis postulates that in test subjects with non-allergic rhinitis the allergy can only
      be proven locally in nasal secretion.

      From the initial large cohort of patients, 24 subjects with house dust mite allergy and
      allergic rhinitis and 24 patients with non-allergic rhinitis will be selected and
      investigated in more detail at a second visit. At the second visit, blood and nasal secretion
      (measurement of local IgE) will be taken from all pre-selected 48 patients. At visit 2 a
      nasal provocation test with house dust mite allergen will be performed in all patients to
      compare nasal symptoms with the results of local IgE between patient groups. In addition the
      same investigations will be performed in a group of 20 healthy non-allergic subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">September 19, 2017</completion_date>
  <primary_completion_date type="Actual">August 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of IgE between 24 subjects with non-allergic rhinitis, 24 subjects with allergic rhinitis and 20 healthy subjects.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of specific IgE between 24 subjects with non-allergic rhinitis, 24 subjects with allergic rhinitis and 20 healthy subjects.</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Peak Nasal Inspiratory Flow as well as the nasal symptoms in nasal provocation test and local specific IgE.</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Explorative Measures: Comparison of the nasal and serum epitope spectrum with the new mite specific IgE component-chip in subjects with allergic rhinitis.</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Perennial Rhinitis</condition>
  <arm_group>
    <arm_group_label>Allergic rhinitis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinical observation of 24 subjects with nasal symptoms and positive prick test for house dust mite</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-allergic rhinitis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinical observation of 24 subjects with nasal symptoms and negative prick test for house dust mite</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Clinical observation of 20 subjects without nasal symptoms and with negative prick test</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Visit 1:
Physical examination (inspection of nasopharynx, auscultation of heart and lungs)
Completion of a Health Questionnaire
Lung function testing with spirometry
Skin prick test
Visit 2:
Physical examination (inspection of nasopharynx, auscultation of heart and lungs)
Measurement of nitric oxide in expired air (FeNO)
Taking nasal secretion samples with a cotton carrier for 15 min
Nasal provocation test with dust mite
Blood sample collection to define blood count, IgE and specific IgE</description>
    <arm_group_label>Allergic rhinitis</arm_group_label>
    <arm_group_label>Non-allergic rhinitis</arm_group_label>
    <arm_group_label>Healthy Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Seasonal or all-season symptoms of an allergic or non-allergic rhinitis

          -  Healthy non-allergic subjects

        Exclusion Criteria:

          -  Patients: Age &lt;18 and &gt; 45

          -  Other severe diseases (e.g. Cystic fibrosis, diseases with immunosuppression,
             malignant diseases)

          -  Previously occurred allergic shock

          -  Pregnancy and lactation

          -  Participation in another clinical trial within the last 30 days

          -  Inability to measure the length and the consequences of the study

          -  Frequent use of medication which could not be discontinued in the defined time before
             enrollment: nasal vasoconstrictors 1 day; antihistamines 3 days; nasal steroids 7
             days; oral cortison 4 weeks; leukotriene antagonists and cromolyn 2 days before NPT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Zielen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department for children and adolescents, division of allergy, pneumology, and cystic fibrosis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Goethe University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Bez C, Schubert R, Kopp M, Ersfeld Y, Rosewich M, Kuehr J, Kamin W, Berg AV, Wahu U, Zielen S. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis. Clin Exp Allergy. 2004 Jul;34(7):1079-85.</citation>
    <PMID>15248853</PMID>
  </reference>
  <reference>
    <citation>Litvyakova LI, Baraniuk JN. Nasal provocation testing: a review. Ann Allergy Asthma Immunol. 2001 Apr;86(4):355-64; quiz 364-5, 386. Review.</citation>
    <PMID>11345277</PMID>
  </reference>
  <results_reference>
    <citation>Buslau A, Voss S, Herrmann E, Schubert R, Zielen S, Schulze J. Can we predict allergen-induced asthma in patients with allergic rhinitis? Clin Exp Allergy. 2014 Dec;44(12):1494-502. doi: 10.1111/cea.12427.</citation>
    <PMID>25270425</PMID>
  </results_reference>
  <results_reference>
    <citation>Campo P, Rond√≥n C, Gould HJ, Barrionuevo E, Gevaert P, Blanca M. Local IgE in non-allergic rhinitis. Clin Exp Allergy. 2015 May;45(5):872-881. doi: 10.1111/cea.12476. Review.</citation>
    <PMID>25495772</PMID>
  </results_reference>
  <results_reference>
    <citation>Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet. 1975 Jul 26;2(7926):148-50.</citation>
    <PMID>49744</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2016</study_first_submitted>
  <study_first_submitted_qc>June 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2016</study_first_posted>
  <last_update_submitted>November 29, 2017</last_update_submitted>
  <last_update_submitted_qc>November 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Stefan Zielen</investigator_full_name>
    <investigator_title>Professor of pediatrics, allergy, pneumology, cystic fibrosis</investigator_title>
  </responsible_party>
  <keyword>Local IgE</keyword>
  <keyword>Non-allergic rhinitis</keyword>
  <keyword>Allergic rhinitis to house dust mite</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Common Cold</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

